You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Theophylline And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Theophylline And Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline And Dextrose 5% In Plastic Container

A generic version of THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityN/A
LG ChemPhase 1
Medical College of WisconsinPhase 1/Phase 2

See all THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-007 Jul 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-005 Jul 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-003 Jul 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-001 Jul 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 018649-002 Jul 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.